Effect of Salovum® on Pressure, Oxygen and Inflammation in Glioblastoma
Clinical trial NCT07364786 · RECRUITING
Trial details
- NCT number
- NCT07364786
- Sponsor
- Peter Siesjö
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-07
- Primary completion
- 2026-10-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.